BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7512523)

  • 1. Primary malignant lymphoma of the uterine cervix shows favorable response to neoadjuvant chemotherapy.
    Kuo HC; Chou CY; Chang CH; Liu MT; Tzeng CC; Huang KE
    Gynecol Oncol; 1994 Mar; 52(3):408-10. PubMed ID: 7512523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant combined chemotherapy followed by external whole pelvic irradiation in two cases of primary extranodal non-Hodgkin's lymphoma of the uterine cervix.
    Heredia F; Bravo M; Pierotic M; Majlis A; Carmona L
    Gynecol Oncol; 2005 Apr; 97(1):285-7. PubMed ID: 15790479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful pregnancy in stage IE primary non-Hodgkin's lymphoma of uterine cervix treated with neoadjuvant chemotherapy and conservative surgery.
    Lorusso D; Ferrandina G; Pagano L; Gagliardi ML; Scambia G
    Oncology; 2007; 72(3-4):261-4. PubMed ID: 18185021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
    Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
    Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The COP-BLAM therapy for malignant lymphoma].
    Arai N; Hara A; Umeda M; Shirai T
    Rinsho Ketsueki; 1990 Jul; 31(7):951-7. PubMed ID: 1699008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features of six cases of primary cervical lymphoma.
    Chan JK; Loizzi V; Magistris A; Hunter MI; Rutgers J; DiSaia PJ; Berman ML
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):866-72. PubMed ID: 16150291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary malignant lymphoma of the uterine cervix: is radiotherapy the best therapeutic choice for stage IE?
    Awwad JT; Khalil AM; Shamseddine AI; Mufarrij AA
    Gynecol Oncol; 1994 Jan; 52(1):91-3. PubMed ID: 8307508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.
    Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM; Chang MF; Shum HC
    Gynecol Oncol; 1997 Mar; 64(3):456-62. PubMed ID: 9062150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of neoadjuvant chemotherapy prior to radical hysterectomy and/or radiation therapy in the management of advanced carcinoma of the uterine cervix.
    Bloss JD; Lucci JA; DiSaia PJ; Manetta A; Schiano MA; Ramsinghani N; Berman ML
    Gynecol Oncol; 1995 Oct; 59(1):105-10. PubMed ID: 7557594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report.
    Szánthó A; Bálega J Já; Csapó Z; Sréter L Lí; Matolcsy A; Papp Z
    Gynecol Oncol; 2003 Apr; 89(1):171-4. PubMed ID: 12694673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary non-Hodgkin's lymphoma presenting as a uterine cervical mass.
    Ab Hamid S; Wastie ML
    Singapore Med J; 2008 Mar; 49(3):e73-5. PubMed ID: 18362991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients.
    Garavaglia E; Taccagni G; Montoli S; Panacci N; Ponzoni M; Frigerio L; Mangili G
    Gynecol Oncol; 2005 Apr; 97(1):214-8. PubMed ID: 15790461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
    Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
    Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoma of uterine cervix.
    Khoury GG; Robinson A
    Eur J Surg Oncol; 1989 Feb; 15(1):65-7. PubMed ID: 2645175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary malignant lymphoma of the cervix. A case report.
    Gabriele A; Gaudiano L
    J Reprod Med; 2003 Nov; 48(11):899-901. PubMed ID: 14686025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant non-Hodgkin's lymphoma of the cervix. A case report].
    Winer N; Maisonneuve H; Magois C; Sagot P; Lopes P; Boog G; Darnis E
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(1):25-9. PubMed ID: 7730562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Maneo A; Chiari S; Bonazzi C; Mangioni C
    Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
    Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-hodgkin's malignant lymphoma in the uterine cervix].
    Makarewicz R; Swirska M; Terlikiewicz J
    Wiad Lek; 1993 Dec; 46(23-24):936-7. PubMed ID: 7900393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.